Humana (HUM)
Members of Humana Inc (NYSE:HUM).’s (the “Company”) senior management team are scheduled to meet with investors and analysts at industry conferences and various other meetings between September 3, 2024 and September 30, 2024. During these conferences and meetings, the Company intends to reaffirm its guidance of approximately $12.81 in diluted earnings per common share (“EPS”) or approximately $16.00 in adjusted earnings per common share (“Adjusted EPS”), in each case for the year ending December 31, 2024 (“FY 2024”). This guidance is consistent with the guidance issued in Humana’s press release dated July 31, 2024. The date and time of presentations to investors are available via the Investor Relations calendar of events on the Company’s website at www.humana.com.
The Company has included Adjusted EPS in this current report, a financial measure that is not in accordance with Generally Accepted Accounting Principles (“GAAP”). Management believes that this measure, when presented in conjunction with the comparable measure of GAAP EPS, provides a comprehensive perspective to more accurately compare and analyze the Company’s core operating performance over time. Consequently, management uses Adjusted EPS as a consistent and uniform indicator of the Company’s core business operations from period to period, as well as for planning and decision-making purposes and in determination of incentive compensation. Adjusted EPS should be considered in addition to, but not as a substitute for, or superior to, GAAP EPS. A reconciliation of GAAP EPS to Adjusted EPS follows:
Diluted earnings per common share | FY 2024 Guidance | ||||
GAAP | approximately $12.81 | ||||
Amortization of identifiable intangibles | 0.50 | ||||
Put/call valuation adjustments associated with Company's non-consolidating minority interest investments | 1.65 | ||||
Impact of exit of employer group commercial medical products business | 1.21 | ||||
Value creation initiatives | 0.80 | ||||
Cumulative net tax impact of non-GAAP adjustments | (0.97) | ||||
Adjusted (non-GAAP) – FY 2024 projected | approximately $16.00 |
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.
HUM: is this perennial leader facing new challenges?
With valuations skyrocketing in 2024, many investors are uneasy putting more money into stocks. Sure, there are always opportunities in the stock market – but finding them feels more difficult now than a year ago. Unsure where to invest next? One of the best ways to discover new high-potential opportunities is to look at the top performing portfolios this year. ProPicks AI offers 6 model portfolios from Investing.com which identify the best stocks for investors to buy right now. For example, ProPicks AI found 9 overlooked stocks that jumped over 25% this year alone. The new stocks that made the monthly cut could yield enormous returns in the coming years. Is HUM one of them?
Unlock ProPicks AI to find out